EP4185318
LANGVARANDI MEÐFERÐARÁFORM MEÐ STÓRUM SKÖMMTUM AF VEGF-BLOKKUM VIÐ ÆÐAMYNDANDI AUGNRÖSKUNUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.5.2022EP published:
3.9.2025EP application number:
22728724.0
EP translation filed:
25.9.2025Grant published:
15.10.2025EPO information:
European Patent Register
Max expiry date:
15.5.2042Expiry date:
15.5.2027Next due date:
31.5.2027
Title in English:
EXTENDED, HIGH DOSE VEGF ANTAGONIST REGIMENS FOR TREATMENT OF ANGIOGENIC EYE DISORDERSLanguage of the patent:
English
Timeline
Today
16.5.2022EP application
3.9.2025EP Publication
25.9.2025Translation submitted
15.10.2025Registration published
15.5.2027Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Name:
Bayer HealthCare LLCAddress:
100 Bayer Boulevard, Whippany, NJ 07981, US
Inventor
Name:
VITTI, Robert L.Address:
Tarrytown, New York 10591, US
Name:
BERLINER, Alyson J.Address:
Tarrytown, New York 10591, US
Name:
CHU, KarenAddress:
Tarrytown, New York 10591, US
Name:
ASMUS, FriedrichAddress:
14129 Berlin, DE
Name:
DA SILVA LEAL, Sergio CasimiroAddress:
4153 Reinach, CH
Name:
EISSING, ThomasAddress:
40764 Langenfeld, DE
Name:
RITTENHOUSE, Kay D.Address:
Randolph, NJ 07869, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
202163189541 PDate:
17.5.2021Country:
US
Number:
202163235398 PDate:
20.8.2021Country:
US
Number:
202263297420 PDate:
7.1.2022Country:
US
Number:
202263306315 PDate:
3.2.2022Country:
US
Classification
Categories:
A61K 38/17, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 11.5.2026
Expires: 15.5.2027
Payer: Árnason Faktor ehf.